Upregulation of IL-23 expression in patients with chronic hepatitis B is mediated by the HBx/ERK/NF-κB pathway

Journal of Immunology

Volumn 188, Issue 2, 2012, Pages 753-764

  Xia, Limin ^a,b   Tian, Dean ^b   Huang, Wenjie ^c   Zhu, Hongwu ^a   Wang, Jing ^a   Zhang, Yongguo ^a   Hu, Hao ^a   Nie, Yongzhan ^a   Fan, Daiming ^a   Wu, Kaichun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B VIRUS X PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 23; INTERLEUKIN 23P19; INTERLEUKIN 23P40; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GENE TRANSLOCATION; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; HISTOLOGICAL ACTIVITY INDEX SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SUBUNIT; SCORING SYSTEM; TRANSACTIVATION; UPREGULATION; VIRUS LOAD;

ADOLESCENT; ADULT; FEMALE; HEP G2 CELLS; HEPATITIS B, CHRONIC; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-23; INTERLEUKIN-23 SUBUNIT P19; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; NF-KAPPA B; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; YOUNG ADULT;

EID: 84862933068     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101652     Document Type: Article

References (46)

1. Dienstag, J. L. 2008. Hepatitis B virus infection. N. Engl. J. Med. 359: 1486-1500.
2. Ganem, D., and A. M. Prince. 2004. Hepatitis B virus infection - natural history and clinical consequences. N. Engl. J. Med. 350: 1118-1129. (Pubitemid 38298992)
3. Rehermann, B., and M. Nascimbeni. 2005. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5: 215-229. (Pubitemid 40364823)
4. Chang, J. J., and S. R. Lewin. 2007. Immunopathogenesis of hepatitis B virus infection. Immunol. Cell Biol. 85: 16-23. (Pubitemid 46067317)
5. Bertoletti, A., and A. J. Gehring. 2006. The immune response during hepatitis B virus infection. J. Gen. Virol. 87: 1439-1449. (Pubitemid 43827198)
6. Rehermann, B. 2000. Intrahepatic T cells in hepatitis B: viral control versus liver cell injury. J. Exp. Med. 191: 1263-1268. (Pubitemid 30227115)
7. Zhang, X., H. Zhang, and L. Ye. 2006. Effects of hepatitis B virus X protein on the development of liver cancer. J. Lab. Clin. Med. 147: 58-66. (Pubitemid 43188997)
8. Arbuthnot, P., A. Capovilla, and M. Kew. 2000. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J. Gastroenterol. Hepatol. 15: 357-368. (Pubitemid 30262201)
9. Bouchard, M. J., and R. J. Schneider. 2004. The enigmatic X gene of hepatitis B virus. J. Virol. 78: 12725-12734. (Pubitemid 39507781)
10. Diao, J., R. Garces, and C. D. Richardson. 2001. X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev. 12: 189-205. (Pubitemid 32588145)
11. Sung, W. K., Y. Lu, C. W. Lee, D. Zhang, M. Ronaghi, and C. G. Lee. 2009. Deregulated direct targets of the hepatitis B virus (HBV) protein, HBx, identified through chromatin immunoprecipitation and expression microarray profiling. J. Biol. Chem. 284: 21941-21954.
12. Ghosh, S., and M. S. Hayden. 2008. New regulators of NF-kappaB in inflammation. Nat. Rev. Immunol. 8: 837-848.
13. Hunter, C. A. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5: 521-531. (Pubitemid 40961330)
14. Lyakh, L., G. Trinchieri, L. Provezza, G. Carra, and F. Gerosa. 2008. Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol. Rev. 226: 112-131.
15. Boniface, K., B. Blom, Y. J. Liu, and R. de Waal Malefyt. 2008. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol. Rev. 226: 132-146.
16. Murphy, C. A., C. L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R. A. Kastelein, J. D. Sedgwick, and D. J. Cua. 2003. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198: 1951-1957. (Pubitemid 38032126)
17. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748. (Pubitemid 36227625)
18. Wiekowski, M. T., M. W. Leach, E. W. Evans, L. Sullivan, S. C. Chen, G. Vassileva, J. F. Bazan, D. M. Gorman, R. A. Kastelein, S. Narula, and S. A. Lira. 2001. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J. Immunol. 166: 7563-7570. (Pubitemid 32525637)
19. Zhu, C., R. Zhang, L. Liu, S. T. Rasool, Y. Mu, W. Sun, Q. Hao, F. Liu, Y. Zhu, and J. Wu. 2009. Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro. Clin. Immunol. 131: 92-97.
20. Zhang, Y., C. J. Ma, L. Ni, C. L. Zhang, X. Y. Wu, U. Kumaraguru, C. F. Li, J. P. Moorman, and Z. Q. Yao. 2011. Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infection. J. Immunol. 186: 3093-3103.
21. Zeuzem, S., and V. Carreño. 2001. Interleukin-12 in the treatment of chronic hepatitis B and C. Antiviral Res. 52: 181-188. (Pubitemid 32973693)
22. Ma, C. J., L. Ni, Y. Zhang, C. L. Zhang, X. Y. Wu, A. N. Atia, P. Thayer, J. P. Moorman, and Z. Q. Yao. 2011. PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes/macrophages during chronic hepatitis C virus infection. Immunology 132: 421-431.
23. Zhang, J. Y., Z. Zhang, F. Lin, Z. S. Zou, R. N. Xu, L. Jin, J. L. Fu, F. Shi, M. Shi, H. F. Wang, and F. S. Wang. 2010. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 51: 81-91.
24. Wu, W., J. Li, F. Chen, H. Zhu, G. Peng, and Z. Chen. 2010. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J. Gastroenterol. Hepatol. 25: 750-757.
25. Ge, J., K. Wang, Q. H. Meng, Z. X. Qi, F. L. Meng, and Y. C. Fan. 2010. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J. Clin. Immunol. 30: 60-67.
26. Lok, A. S., and B. J. McMahon. 2007. Chronic hepatitis B. Hepatology 45: 507-539. (Pubitemid 46374607)
27. Scheuer, P. J. 1991. Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 13: 372-374.
28. Mise-Omata, S., E. Kuroda, J. Niikura, U. Yamashita, Y. Obata, and T. S. Doi. 2007. A proximal kappaB site in the IL-23 p19 promoter is responsible for RelAand c-Rel-dependent transcription. J. Immunol. 179: 6596-6603.
29. Carmody, R. J., Q. Ruan, H. C. Liou, and Y. H. Chen. 2007. Essential roles of c-Rel in TLR-induced IL-23 p19 gene expression in dendritic cells. J. Immunol. 178: 186-191. (Pubitemid 46033600)
30. Becker, C., S. Wirtz, X. Ma, M. Blessing, P. R. Galle, and M. F. Neurath. 2001. Regulation of IL-12 p40 promoter activity in primary human monocytes: roles of NF-kappaB, CCAAT/enhancer-binding protein beta, and PU.1 and identification of a novel repressor element (GA-12) that responds to IL-4 and prostaglandin E (2). J. Immunol. 167: 2608-2618. (Pubitemid 32768889)
31. Miller, K. A., N. Yeager, K. Baker, X. H. Liao, S. Refetoff, and A. Di Cristofano. 2009. Oncogenic Kras requires simultaneous PI3K signaling to induce ERK activation and transform thyroid epithelial cells in vivo. Cancer Res. 69: 3689-3694.
32. Bates, M. E., J. B. Sedgwick, Y. Zhu, L. Y. Liu, R. G. Heuser, N. N. Jarjour, H. Kita, and P. J. Bertics. 2010. Human airway eosinophils respond to chemoattractants with greater eosinophil-derived neurotoxin release, adherence to fibronectin, and activation of the Ras-ERK pathway when compared with blood eosinophils. J. Immunol. 184: 7125-7133.
33. Morton, A. M., B. McManus, P. Garside, A. M. Mowat, and M. M. Harnett. 2007. Inverse Rap1 and phospho-ERK expression discriminate the maintenance phase of tolerance and priming of antigen-specific CD4+ T cells in vitro and in vivo. J. Immunol. 179: 8026-8034.
34. Abraham, C., and J. H. Cho. 2009. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 60: 97-110.
35. Lara-Pezzi, E., P. L. Majano, M. Gómez-Gonzalo, C. García-Monzón, R. Moreno-Otero, M. Levrero, and M. López-Cabrera. 1998. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Hepatology 28: 1013-1021. (Pubitemid 28450262)
36. Lee, M. O., Y. H. Choi, E. C. Shin, H. J. Kang, Y. M. Kim, S. Y. Jeong, J. K. Seong, D. Y. Yu, H. Cho, J. H. Park, and S. J. Kim. 2002. Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection. J. Hepatol. 37: 380-386. (Pubitemid 34969954)
37. Mahé, Y., N. Mukaida, K. Kuno, M. Akiyama, N. Ikeda, K. Matsushima, and S. Murakami. 1991. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. J. Biol. Chem. 266: 13759-13763. (Pubitemid 21907416)
38. Zhou, Y., S. Wang, J. W. Ma, Z. Lei, H. F. Zhu, P. Lei, Z. S. Yang, B. Zhang, X. X. Yao, C. Shi, et al. 2010. Hepatitis B virus protein X-induced expression of the CXC chemokine IP-10 is mediated through activation of NF-kappaB and increases migration of leukocytes. J. Biol. Chem. 285: 12159-12168.
39. Xia, L. M., W. J. Huang, J. G. Wu, Y. B. Yang, Q. Zhang, Z. Z. Zhou, H. F. Zhu, P. Lei, G. X. Shen, and D. A. Tian. 2009. HBx protein induces expression of MIG and increases migration of leukocytes through activation of NF-kappaB. Virology 385: 335-342.
40. Sanjabi, S., A. Hoffmann, H. C. Liou, D. Baltimore, and S. T. Smale. 2000. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl. Acad. Sci. USA 97: 12705-12710.
41. Li, Q., and I. M. Verma. 2002. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2: 725-734.
42. Sun, S. C., and S. C. Ley. 2008. New insights into NF-kappaB regulation and function. Trends Immunol. 29: 469-478.
43. Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-kappaB. Genes Dev. 18: 2195-2224.
44. Huang, G., L. Z. Shi, and H. Chi. 2009. Regulation of JNK and p38 MAPK in the immune system: signal integration, propagation and termination. Cytokine 48: 161-169.
45. Liu, Y., E. G. Shepherd, and L. D. Nelin. 2007. MAPK phosphatases - regulating the immune response. Nat. Rev. Immunol. 7: 202-212.
46. Favata, M. F., K. Y. Horiuchi, E. J. Manos, A. J. Daulerio, D. A. Stradley, W. S. Feeser, D. E. Van Dyk, W. J. Pitts, R. A. Earl, F. Hobbs, et al. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273: 18623-18632. (Pubitemid 28334795)